Wang, S C; Makino, K; Su, L K et al. (2001) Ultraviolet irradiation induces BRCA2 protein depletion through a p53-independent and protein synthesis-dependent pathway. Cancer Res 61:2838-42
|
Hortobagyi, G N; Ueno, N T; Xia, W et al. (2001) Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a phase I clinical trial. J Clin Oncol 19:3422-33
|
Yu, D; Hung, M C (2000) Role of erbB2 in breast cancer chemosensitivity. Bioessays 22:673-80
|
Yu, D; Hung, M C (2000) Overexpression of ErbB2 in cancer and ErbB2-targeting strategies. Oncogene 19:6115-21
|
Xia, W; Lau, Y K; Zhang, H Z et al. (1999) Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members. Clin Cancer Res 5:4164-74
|
Hong, R L; Spohn, W H; Hung, M C (1999) Curcumin inhibits tyrosine kinase activity of p185neu and also depletes p185neu. Clin Cancer Res 5:1884-91
|
Hung, M C; Lau, Y K (1999) Basic science of HER-2/neu: a review. Semin Oncol 26:51-9
|
Zhang, L; Lau, Y K; Xia, W et al. (1999) Tyrosine kinase inhibitor emodin suppresses growth of HER-2/neu-overexpressing breast cancer cells in athymic mice and sensitizes these cells to the inhibitory effect of paclitaxel. Clin Cancer Res 5:343-53
|
Ueno, N T; Xia, W; Tucker, S D et al. (1999) Issues in the development of gene therapy: preclinical experiments in E1A gene delivery. Oncol Rep 6:257-62
|
Yu, D; Hung, M C (1998) The erbB2 gene as a cancer therapeutic target and the tumor- and metastasis-suppressing function of E1A. Cancer Metastasis Rev 17:195-202
|
Showing the most recent 10 out of 35 publications